118 related articles for article (PubMed ID: 6361754)
1. Critical evaluation of various forms of therapy for idiopathic calcium stone disease.
Marangella M; Tricerri A; Sonego S; Ronzani M; Fruttero B; Daniele PG; Bruno M; Linari F
Proc Eur Dial Transplant Assoc; 1983; 20():434-9. PubMed ID: 6361754
[TBL] [Abstract][Full Text] [Related]
2. Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients.
Strauss AL; Coe FL; Parks JH
Arch Intern Med; 1982 Mar; 142(3):504-7. PubMed ID: 7065787
[TBL] [Abstract][Full Text] [Related]
3. [Preventive medical treatment of recurrent urinary calcium calculi].
François B; Trolliet P; Cahen R; Semet MP
Nephrologie; 1986; 7(1):9-12. PubMed ID: 3960261
[TBL] [Abstract][Full Text] [Related]
4. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences.
Borghi L; Meschi T; Guerra A; Novarini A
J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S78-86. PubMed ID: 7508066
[TBL] [Abstract][Full Text] [Related]
5. [Compared metabolic effects of phosphorus or hydrochlorothiazide therapy in hypercalciuric stone-formers (author's transl)].
Dard S; Ulmann A
Nephrologie; 1981; 2(1):4-7. PubMed ID: 7345375
[TBL] [Abstract][Full Text] [Related]
6. Management of the stone former.
Burns JR; Finlayson B
Semin Urol; 1984 Feb; 2(1):34-44. PubMed ID: 6463460
[No Abstract] [Full Text] [Related]
7. [Etiopathogenesis and clinical aspects of nephrolithiasis--at present].
Ferrari L; Meschi M; Musini S; Frattini A; Savazzi GM
Recenti Prog Med; 2003 Mar; 94(3):136-41. PubMed ID: 12677782
[TBL] [Abstract][Full Text] [Related]
8. The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers.
Favus MJ; Coe FL
Scand J Urol Nephrol Suppl; 1980; 53():265-71. PubMed ID: 6938003
[TBL] [Abstract][Full Text] [Related]
9. Do thiazides prevent recurrent idiopathic renal calcium oxalate stones?
Wolf H; Brocks P; Dahl C
Proc Eur Dial Transplant Assoc; 1983; 20():477-80. PubMed ID: 6361755
[TBL] [Abstract][Full Text] [Related]
10. Outcome of metabolic evaluation and medical treatment for calcium nephrolithiasis in a private urological practice.
Mardis HK; Parks JH; Muller G; Ganzel K; Coe FL
J Urol; 2004 Jan; 171(1):85-8. PubMed ID: 14665850
[TBL] [Abstract][Full Text] [Related]
11. [Idiopathic calcium nephrolithiasis: therapeutic aspects].
Jaeger P; Portmann L; Burckhardt P
Schweiz Med Wochenschr; 1983 Nov; 113(47):1750-6. PubMed ID: 6658421
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic treatment of kidney stone disease.
Eisner BH; Goldfarb DS; Pareek G
Urol Clin North Am; 2013 Feb; 40(1):21-30. PubMed ID: 23177632
[TBL] [Abstract][Full Text] [Related]
13. [Functional evaluation in patients with kidney calculi].
Stojimirović B
Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
[TBL] [Abstract][Full Text] [Related]
14. Metabolic abnormalities associated with calyceal diverticular stones.
Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
[TBL] [Abstract][Full Text] [Related]
15. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study.
Borghi L; Meschi T; Amato F; Briganti A; Novarini A; Giannini A
J Urol; 1996 Mar; 155(3):839-43. PubMed ID: 8583588
[TBL] [Abstract][Full Text] [Related]
16. Calcium restriction, thiazide, citrate, and allopurinol in calcium oxalate nephrolithiasis.
Coe FL
Acta Urol Belg; 1994 Jun; 62(2):25-9. PubMed ID: 8037000
[No Abstract] [Full Text] [Related]
17. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
Pak CY; Sakhaee K; Fuller CJ
Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
[TBL] [Abstract][Full Text] [Related]
18. Effect of acute acid loading on acid-base and calcium metabolism.
Osther PJ
Scand J Urol Nephrol; 2006; 40(1):35-44. PubMed ID: 16452054
[TBL] [Abstract][Full Text] [Related]
19. [Metabolic evaluation of recurrent idiopathic calcium stone disease in Portugal].
Serra A; Domingos F; Salgueiro C; Prata MM
Acta Med Port; 2004; 17(1):27-34. PubMed ID: 15636725
[TBL] [Abstract][Full Text] [Related]
20. [On the question of endocrine side effects in patients on medication for renal calcium stone disease (author's transl)].
Ziegler R; Uhl K; Minne H; Russmann D; Döring B
Urologe A; 1980 Jul; 19(4):226-30. PubMed ID: 7414768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
